Corrigendum to “A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing” [Nanomedicine: Nanotechnology, Biology, and Medicine, 2014;10(3):579–87] (Nanomedicine: Nanotechnology, Biology and Medicine (2014) 10(3) (579–587), (S1549963413005820), (10.1016/j.nano.2013.10.006));A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 3, 2014, Pages 579-587

  Malarvizhi, Giridharan Loghanathan ^a   Chandran, Parwathy ^a   Retnakumari, Archana Payickattu ^a   Ramachandran, Ranjith ^a   Gupta, Neha ^a   Nair, Shantikumar ^a   Koyakutty, Manzoor ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Albumin; Core shell nanomedicine; Metastasis; Photodynamic therapy; PLGA

Indexed keywords

AMINO ACIDS; CELLS; CYTOLOGY; DISEASES; ENZYMES; MEDICAL NANOTECHNOLOGY; PATHOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

ALBUMIN; CORE SHELL; METASTASIS; METASTATIC CANCER CELLS; PHOTODYNAMIC ACTION; PLGA; POLY(LACTIC-CO-GLYCOLIC ACID); TYROSINE KINASE INHIBITOR;

SHELLS (STRUCTURES);

DASATINIB; HUMAN SERUM ALBUMIN; NANOSHELL; PHOTOSENSITIZING AGENT; POLYGLACTIN; PROTEIN TYROSINE KINASE; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ACTIN FILAMENT; ARTICLE; BREAST METASTASIS; CANCER CELL CULTURE; CELL DEATH; CELL MIGRATION; CELL STRUCTURE; COACERVATION; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CYTOTOXICITY; DRUG RELEASE; ELECTROSPRAY; HYDRODYNAMICS; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR DOCKING; NANOENCAPSULATION; NANOMEDICINE; OXIDATIVE STRESS; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; ZETA POTENTIAL;

TETRA;

ALBUMIN; CORE-SHELL NANOMEDICINE; METASTASIS; PHOTODYNAMIC THERAPY; PLGA;

BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DRUG CARRIERS; FEMALE; HUMANS; LACTIC ACID; MESOPORPHYRINS; MOLECULAR DOCKING SIMULATION; NANOMEDICINE; NEOPLASM METASTASIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYGLYCOLIC ACID; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SERUM ALBUMIN; THIAZOLES;

EID: 84896544967     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2019.102021     Document Type: Erratum

References (20)

1. Isaiah J.F. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:1-6.
2. Bremnes R.M., Veve R., Hirsch F.R., Franklin W.A. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002, 36(2):115-124.
3. Palacios F., Tushir J.S., Fujita Y., D'Souza-Schorey C. Lysosomal targeting of Ecadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 2005, 25(1):389-402.
4. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004, 4:118-132.
5. Irby R.B., Yeatman T.J. E-cadherin in colon cancer cells requires integrin signalling. Nature Cell Biol 2002, 4:632-638.
6. Rosalyn B.I., Timothy J.Y. Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res 2002, 62:2669-2674.
7. Valerie G.B., Margaret C.F. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 2008, 8:427-432.
8. Vitale S., Avizienyte E., Brunton V.G., Frame M.C. Focal adhesion kinase is not required for Src-induced formation of invadopodia in KM12C colon carcinoma cells and can interfere with their assembly. Eur J Cell Biol 2008, 87:569-579.
9. Archana P.R., Prasanna L.H., Giridharan L.M., Raghuveer P., Neeraj S., Madhavan V.T., Deepthy M., et al. ACS Molec Pharm 2012, 9:3062-3078.
10. Loo J.S.C., Ooi C.P., Boey F.Y.C. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(l-lactide) (PLLA) by electron beam radiation. Biomaterials 2005, 26:1359-1367.
11. Jilie K., Shaoning Y.U. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin 2007, 39(8):549-559.
12. Parvez I., Haris A., Feride S.B. FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media. J Mol Catal B: Enzym 1999, 7:207-221.
13. Don X.N., Joan M. Genetic determinants of cancer metastasis. Nat Rev Genet 2007, 8:341.
14. Ming L., Jun-Lin G. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 2010, 289:127-139.
15. Makoto N., Daisuke H., Naohiko K., Toshifumi A., Motoharu S. Turnover of focal adhesions and cancer cell migration. Int J Cell Biol 2012, 1-10.
16. Leslie A.C., James F.C., Guan Jun-Lin Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996, 109:1787-1794.
17. Andrew P.G., Lewis H.R. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 1996, 7:1209-1224.
18. Karin L., Thomas K., Sylvia W., Arno W., Andrea E., Klaus L., Hagen V.B. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells. Nanotechnology 2011, 22:1-12.
19. Ana P.C., Tatiana N.D., Michael R.H. Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2005, 2:1-23.
20. Sean M., Smanla T., Donald A.H., Shanta D. Ex-vivo programming of dendritic cell by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy. ACS Nano 2013, 7(8):7392-7402.